Wed, 18 October 2017
Novocure, Precision Medicine, and Celgene are three top healthcare stocks. The team discusses their business models and biggest risks in this edition of “Pitch Week.” |
Tue, 17 October 2017
“Pitch Week” continues on Industry Focus as our Foolish contributors share their takes on Under Armour, Dave & Buster’s, and Tractor Supply Co. Thanks to Harry’s for supporting the Motley Fool. Get your free trial set -- go to Harrys.com/fool. |
Mon, 16 October 2017
We kick off "Pitch Week" with a look at payment companies Mastercard and Square, and wrap the show with a breakdown of why Warren Buffett's Berkshire Hathaway has been such a good business to own. |
Fri, 13 October 2017
Netflix got a nice bump after announcing price increases to several of its service tiers – what might the increases mean for the company’s top line and what should investors be paying attention to ahead of the company’s earnings report next week? |
Thu, 12 October 2017
The U.S. has a huge number of investment opportunities in the well-developed energy industry. We discuss why the U.S. oil and gas sector has developed the way it has, some complexities in investing in overseas energy companies, and a few stocks with foreign flare you might want to consider. |
Wed, 11 October 2017
Mylan launches a generic "at-risk" and Flexion's big drug opportunity becomes clearer. Editor's note: Mylan's drug was mistakenly referred to in the episode as a biosimilar. Copaxone, however, was approved under an NDA, not a BLA, so Mylan's copycat is a generic, not a biosimilar. |
Tue, 10 October 2017
We look at the latest quarterly earnings from some of the top performers in the alcohol and restaurant industries. Slack: Where work happens. Find out why at slack.com. |
Mon, 9 October 2017
Financials takes a look at share buybacks, dividends, and other ways of returning capital to shareholders. |
Fri, 6 October 2017
Now that we have a sense of Roku's valuation, what do we think of it? That, plus a rundown on all the cool new devices Google showed off earlier this week and their impact on the smartphone, smart home and camera markets. Get $25 off your first purchase at http://bombfell.com/fool |
Thu, 5 October 2017
Tesla missed Q3 Model 3 production targets by 83%. We debate how concerned investors should be, some good news from the update, and a potentially exciting development on the horizon. Thanks to Bombfell for supporting The Motley Fool. Get $25 off your first purchase at http://bombfell.com/fool |